"HPV16 circulating tumour DNA for prognostic stratification and post-treatment surveillance in HPV-positive oropharyngeal cancer: A multinational study".
BACKGROUND Improved biomarkers are needed to refine prognosis and enable earlier detection of recurrence in HPV-associated oropharyngeal cancer (OPC). We evaluated the diagnostic performance, clinical associations, prognostic value, and longitudinal surveillance utility of HPV16 circulating tumour DNA (ctDNA) in a mult...